UTSA alumna Jordan Kaufmann wins $50K for new stent-graft start-up
(June 5, 2012) -- Jordan Kaufmann, a recent biomedical engineering Ph.D. graduate of the UTSA College of Engineering, has won the University of Texas Horizon Fund Student Investment Competition and $50,000 in seed funding for developing a new stent-graft that has been shown to prevent aneurysm leakage following cardiovascular surgery.
Kaufmann developed her unique stent-graft as part of her doctoral research in biomedical engineering with faculty advisers Mauli Agrawal, dean of the UTSA College of Engineering, and Steven Bailey, M.D., division chief for cardiology in the School of Medicine of the UT Health Science Center San Antonio. Kaufman plans to use the prize money to help launch Cardiovate, a start-up to develop and market the new technology, which will be the only one of its kind in the $507 million cardiovascular stent-graft market.
"The development of Dr. Kaufmann's new stent-graft and the launch of Cardiovate is testament to the entrepreneurial environment that UTSA has developed in recent years," said Cory Hallam, director of the UTSA Center for Innovation and Technology Entrepreneurship. "The technology has the potential to prevent tens of thousands of aortic aneurysm ruptures, which will ultimately reduce health-care costs and complications for patients."
The UT Horizon Fund Student Investment Competition seeks proposals for promising technology‐based enterprise opportunities led by students from across all 15 University of Texas System institutions. Applicants are required to articulate the business and technical aspects of their venture ideas and communicate their ability to execute and succeed in the venture. UTSA held two of the four finalist spots in this competition.
"We are extremely proud of the work Jordan did in the laboratory while she was a doctoral student at UTSA," said Agrawal. "She is a wonderful ambassador of the UTSA College of Engineering, and we expect to see her doing many great things with Cardiovate and throughout the course of her career."
Approximately 1.2 million people in the U.S. suffer from an abdominal aortic aneurysm. Aneurysm rupture is the nation's 13th leading cause of death. Surgeons perform approximately 65,000 abdominal aortic aneurysm repairs annually.
In a surgical repair procedure called endovascular aneurysm repair, however, one of every six patients experiences stent-graft leakage from traditional stent-grafts in the month following surgery. Additionally, 20 to 30 percent of patients require an additional corrective surgery as much as six to eight years later.
While pursuing her doctoral degree in biomedical engineering at UTSA under the supervision of Agrawal and Bailey, Kaufmann developed a unique scaffold, which promotes tissue formation. The product, called a tissue-engineering scaffold for aneurysm repair (TESAR), creates a tissue barrier between the blood and the aneurysm after it is implanted. The scaffold promotes healthy tissue formation to repave the aneurysm wall. Once the scaffold is in place, the aneurysm stops expanding and the risk of rupture decreases. After new tissue is in place, the scaffold degrades and is safely reabsorbed by the body.
Kaufmann's TESAR stent-graft has been shown in the laboratory to reduce post-operative complications during aneurysm repair surgery, such as the need for additional corrective surgeries following the initial procedure. Also, the natural tissue is a better match for biological healing than the materials found in traditional stent-grafts.
"Through her efforts, Jordan has potentially improved outcomes for countless patients," said Bailey. "I am pleased to have mentored an up-and-coming scientist of her caliber, and I look forward to her future achievements."
Between now and March 2013, Kaufmann, Agrawal and Bailey will work together to refine the manufacturing of the TESAR, and they will test it to ensure it conforms to the highest safety and quality standards. The scholars expect to make the product available for licensing to a larger company in 2013. Ideally, it would be on the market for vascular surgeons to use shortly after being evaluated by the FDA.
Make the most of your college experience by applying to be part of the 2020 Homecoming Court or the next Mr. or Ms. UTSA. Applications are now open for the Homecoming Court—from which Mr. & Ms. UTSA 2021 will be selected. Deadline is Friday, July 31 at 11:59 p.m.Virtual Event
Are you successful in your goals and activities? How do you know? Analyze current and past personal and team goals and effectively evaluate progress.Virtual Event
Your student organization can stay engaged this summer with the Student Organization Impact Series to help prep organization leaders on how to best guide an organization for the new academic year.Virtual Event
What is ethical leadership? Examine definitions, necessary principles and practice skills to navigate potentially challenging situations in the workplace, school settings and personal life.Virtual Event
In this Zoom forum, UTSA faculty and students are invited to participate in a discussion on how we can work collaboratively on creating a better experience for digital courses.Virtual Event
Grab your grub and drop in for a lively lunchtime conversation with this series on the culture and business of food in San Antonio. Free and open to the public.Virtual Town Event
Get your thinking caps on for a livestream game night like no other. The gaming will include a scavenger hunt, secret words, chat-room challenges and more.Virtual Event